Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected Adults
Clinical trial NCT00097838 · COMPLETED
Trial details
- NCT number
- NCT00097838
- Sponsor
- AlphaVax, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2009-09-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.